Cargando…

The protective side of progesterone

Detalles Bibliográficos
Autores principales:	Ferretti, Gianluigi, Felici, Alessandra, Cognetti, Francesco
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246175/ https://www.ncbi.nlm.nih.gov/pubmed/18086325 http://dx.doi.org/10.1186/bcr1792

Ejemplares similares

Controversies on autoimmunity and prognosis in cancer
por: Ferretti, G, et al.
Publicado: (2006)

Ras oncogene mutations and survival in patients with lung cancer
por: Ferretti, G, et al.
Publicado: (2006)

Is thymidylate synthase a reliable predictor for response and survival during hepatic arterial infusion for hepatic metastases from colorectal cancer?
por: Ferretti, G, et al.
Publicado: (2006)

Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022)

Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
por: Falcone, Italia, et al.
Publicado: (2020)

Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement
por: Conciatori, Fabiana, et al.
Publicado: (2019)

S-Fluorenylmethyl protection of the cysteine side chain upon N(α)-Fmoc deprotection
por: Wehner, Johannes W, et al.
Publicado: (2012)

Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.
por: Lancaster, J. M., et al.
Publicado: (1998)

Forkhead box P3-positive regulatory T cells in immune surveillance and cancer
por: Ferretti, G, et al.
Publicado: (2007)

Progesterone supplementation – Beware of changes in the oral cavity
por: Singh, Preetinder, et al.
Publicado: (2013)

Comment on ‘Renewed interest in the progesterone receptor in breast cancer’
por: Simone, Giovanni, et al.
Publicado: (2017)

Successful Experience of Cyclic Progesterone Supplementation in Catamenial Epilepsy
por: Kim, Jon Soo, et al.
Publicado: (2020)

A case of recurrent retroperitoneal lymphangioleiomyomatosis treated with progesterone therapy
por: Basnet, Alina, et al.
Publicado: (2015)

Vaccination side effects
por: Dziedzic, A., et al.
Publicado: (2021)

No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.
por: Manolitsas, T. P., et al.
Publicado: (1997)

PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy
por: Conciatori, Fabiana, et al.
Publicado: (2020)

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy
por: Fabi, Alessandra, et al.
Publicado: (2012)

Left-sided Amyand hernia
por: Johari, Hamed Ghoddusi, et al.
Publicado: (2009)

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients
por: Fabi, Alessandra, et al.
Publicado: (2015)

Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline
por: Volontè, Martina, et al.
Publicado: (2022)

Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling
por: Meier-Abt, Fabienne, et al.
Publicado: (2014)

Reply to the letter entitled: Re: The first report on Covid-19 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey
por: Di Noia, Vincenzo, et al.
Publicado: (2021)

If Progesterone Is Blamed for Breast Cancer Development, Why Are We Still Using Tamoxifen?
por: Özkaya, Enis, et al.
Publicado: (2013)

Chlamydia inhibits progesterone receptor mRNA expression in SHT-290 cells
por: Brown, Megan, et al.
Publicado: (2021)

Protective Effect of Progesterone during Pregnancy against Ovarian Cancer
por: Han, Kyung Hee, et al.
Publicado: (2013)

AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
por: Falcone, Italia, et al.
Publicado: (2020)

Progesterone Hypersensitivity Induced by Exogenous Progesterone Exposure
por: Dhaliwal, Gurnoor, et al.
Publicado: (2023)

Progesterone Is Essential for Protecting against LPS-Induced Pregnancy Loss. LIF as a Potential Mediator of the Anti-inflammatory Effect of Progesterone
por: Aisemberg, Julieta, et al.
Publicado: (2013)

Female sex hormone, progesterone, ameliorates the severity of SARS-CoV-2-caused pneumonia in the Syrian hamster model
por: Yuan, Lunzhi, et al.
Publicado: (2022)

Oral side effects of COVID-19 vaccine
por: Riad, A.
Publicado: (2021)

Does progesterone have protective effects on ovarian ischemia-reperfusion injury?
por: Güleç Başer, Banu, et al.
Publicado: (2018)

Left Sided Gastroschisis
por: Rahul, Sandip Kumar, et al.
Publicado: (2017)

Progesterone: The Key Factor of the Beginning of Life
por: Bulletti, Carlo, et al.
Publicado: (2022)

Improving the “urinary side” of acute kidney injury monitoring
por: Maciel, Alexandre Toledo, et al.
Publicado: (2016)

Dietary Progesterone Contributes to Intratissue Levels of Progesterone in Male Mice
por: Colldén, Hannah, et al.
Publicado: (2023)

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials
por: Rossi, Valentina, et al.
Publicado: (2019)

Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition
por: Conciatori, Fabiana, et al.
Publicado: (2022)

Unusual side effects with acamprosate
por: Sidana, Ajeet Kumar, et al.
Publicado: (2007)

Conjoined Twins: The Flip Side
por: Batool, Tayyab, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9e1n16g4qu680iacra1fpru19e